(Reuters) – The U.S. Food and Drug Administration on Friday approved a non-hormonal therapy from Japanese drugmaker Astellas Pharma Inc for treatment of symptoms associated with menopause.
(Reporting by Raghav Mahobe in Bengaluru; Editing by Shounak Dasgupta)
